

Three decades ago, in October 1995, an international group of researchers convened in Newcastle upon Tyne (England, UK) for the inaugural meeting of the Dementia with Lewy Bodies Consortium. This landmark event laid the foundation for the Consortium's work in establishing clinical and pathological diagnostic criteria. The Consortium's work subsequently expanded to include proposed management guidelines, identification of prodromal forms of the condition, and use of biomarkers to support diagnosis.
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet